RNS Announcements
6Replacement: Result of Annual General Meeting
the Company. All other details remain unchanged. The full amended text is shown below. Science in Sport plc ("Science in Sport", "the Company" or the "Group") Result of Annual General Meeting Science in Sport plc (AIM: SIS) , the premium performance nutrition company serving elite athletes, sports enthusiasts, and the active lifestyle community, held its Annual General Meeting (AGM) at 9:30 am today. All Resolutions, as set out in the Notice of Meeting dated 28 June 2024, were duly passed. The table below shows the proxy position for all Resolutions: SS FOR AGAINST WITHHE…
Replacement: Director/PDMR Shareholding
the Company, the net impact of which should have been an increase in Lombard Odier Asset Management (Europe) Limited's holding in the Company of 14,705,882 Ordinary Shares. Amendments are identified with an asterisk. All other details remain unchanged. The full amended text is shown below. Science in Sport plc (" Science in Sport " or the "Company") Director/PDMR Shareholding Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, announces that it has been notified of the following tran…
Result of the Retail Offer
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT. Science in Sport plc (the "Company" or the "Group") Result of the Retail Offer Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite at…
Result of Placing and director dealings
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. PERSONS INTO WHOSE POSSESSION THIS ANNOUNCEMENT COMES ARE REQUIRED BY SCIENCE IN SPORT PLC AND PANMURE LIBERUM LIMITED TO INFORM THEMSELVES ABOUT AND TO OBSERVE ANY SUCH RESTRICTIONS. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION (EU) 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN…
Retail Offer for up to £0.5 million
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT. THE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS RELATING TO THE RETAIL OFFER AS A FINANCIAL PROMOTION IS ONLY BEING MADE TO, AND MAY ONLY BE ACTED UPON BY, …
Proposed Placing and Retail Offer
THIS ANNOUNCEMENT (INCLUDING THE APPENDICES) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN AN INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PER…
LinkedIn Activity
7More Exciting News! BookBuild is thrilled to announce the successful conclusion of the latest Retail Offer for Proteome Sciences plc which was significantly oversubscribed. Thanks to SP Angel.
BookBuild's own company page uses promotional language ('Exciting News!', 'thrilled', 'significantly oversubscribed') without any risk disclaimers. Contrast with RetailBook's posts which include risk warnings.
Savannah Resources' own LinkedIn page and Proactive Investors posted about multiple fundraises: a £9.2m oversubscribed placing and subscription (scaled back from higher demand), a £6.5m fundraise at market price made available to private investors via PrimaryBid (July 2023), a £6.1m placing and subscription, and a further £1m placing to a major shareholder. The retail offer component via PrimaryBid was highlighted as providing retail shareholder access. CEO also discussed Barroso lithium project funding on Proactive.
LinkedIn posts from company page: linkedin.com/company/savannah-resources-plc. Proactive post: linkedin.com/posts/proactive-investors_savannah-resources-ceo-outlines-way-forward-activity-7348705237223833601. Pattern of repeat raises with PrimaryBid retail component is consistent with the 'repeat raises' concern.
2026 outlook post highlighting clinical milestones: POLB 001 TOPICAL trial interim data expected summer 2026, Oral GLP-1 PoC topline data expected H1 2026. States company is 'funded through this catalyst-rich period, with a cash runway extending into 2027'.
No direct fundraise announcement found on LinkedIn for Poolbeg. This post emphasises cash runway to 2027. No BookBuild or retail targeting language found in any Poolbeg LinkedIn posts. A separate profile (Michael Fleming) mentioned participating in a Poolbeg share placing with £100k investment, but post not directly accessible. URL: https://www.linkedin.com/posts/poolbeg-pharma_polb-catalystrich-aim-activity-7415289997668360192-LCu-
DWF advised Zinnwald Lithium on £18.75m equity fundraise closed at a premium to share price. Cornerstone investment from AMG Advanced Metallurgical Group. Launched and closed in under 16 hours. Worked with Nomad Allenby Capital and co-brokers Tamesis Partners and Oberon Capital.
Post from legal adviser celebrating deal completion. Mentions AMG cornerstone but no mention of 29.57% concentration risk. No disclaimers.
CurrentBody parent Beauty Tech Group heading for London IPO. Valuation range £280-£320m. Revenue £101m, EBITDA £22.9m. New shares raising £29m, total offer size £106.5m (~35.5% of issued share capital). Founded 2009, backed by eComplete and Simon Cooper.
Pre-IPO analysis post with detailed financial metrics. No risk warnings or disclaimers despite providing valuation and investment-relevant data. Describes as 'rare D2C brand with global traction and clinical credibility'.
"Mendell Helium plc has launched with InvestorHub." CEO Nick Tulloch discussed helium production from M3 Helium's Kansas operations, Rost well dewatering, plans for a Bitcoin treasury policy, and an intended move to AIM listing. Emphasised "building long-term trust" through shareholder communication.
Mentions Bitcoin treasury policy -- relevant to the HIGH-severity finding about bitcoin treasury + helium combination. No risk warnings.
Detailed post about Mendell Helium's Rost 1-26 well production initiation. Quotes: "The well is flowing more than 100 thousand cubic feet of gas per day with a helium concentration of 5.1% resulting in an estimated daily helium revenue of over US $1,600." Emphasises helium market growth from $4.1bn (2024) to $6bn by 2030. M3 Helium acquisition option discussed.
Market-positive framing emphasising commercial opportunity without counterbalancing volatility considerations or acquisition contingencies. Highest engagement (49 reactions) of all MDH posts found.